|Day Low/High||27.12 / 27.84|
|52 Wk Low/High||12.81 / 29.97|
Insiders at these companies have been scooping up shares of their own stock lately.
These stocks will be up so high today, that many fans will say "no thanks."
Meeting to Include an Oral Presentation of the Results of the ACTIVExtend Trial in the Plenary Session
Halfway through an ugly week, the question on investors' minds is, what needs to happen to get the market headed in the right direction? Jim Cramer has a long checklist.
Jim Cramer answers viewers' Twitter (TWTR) questions from the floor of the New York Stock Exchange. He weighs in on Apple (AAPL), Alcoa (AA), Walgreens (WBA), Disney (DIS) and more.
Catch up on Jim Cramer's ideas from this past week as he discusses how the E.U. abetted the Greek crisis, good news we're ignoring, and whether it's time to bargain-hunt.
Cramer tells TheStreet's Brittany Umar he is working on a surprise piece that will 'blow the doors off' McDonald's.
Jim Cramer likes Soutwest (LUV), isn't a fan of Sarepta Therapeutics (SRPT) and will soon have a 'surprise' piece on McDonald's (MCD).
A quarter of the market bottomed today, which means stocks in biotech, among other areas, were there for the taking, Cramer says.
And now he's in electioneering mode at its worst.
I wonder why skepticism disappears so quickly these days.
Cramer says Home Depot and Lowe's are how you play the resurgence in home buying while Nike reminds us why we invest in the first place.
The bulls got complacent and they paid the price Monday, Cramer says.
Cramer says UnitedHealth is a best of breed health insurer and Ambarella is more than just GoPro.
Investors stopped worrying about Greece and chose from a menu of great stocks with long-term growth potential, Cramer says.
Cramer says BioMarin, Radius Health and Allergan are winners but stay away from Diageo.
The Federal Reserve statement, Greece, selling the dollar and investor confidence all had a hand, Cramer says.
Sequential Brands (SQBG) and Martha Stewart Living Omnimedia (MSO) rocketed higher by late afternoon Thursday.
TheStreet's Jim Cramer praised Radius Health and BioMarin for their treatments results, which prompted a slew of analyst price target increases.
Radius Health (RDUS) shares are up over 15% after the company reported positive results from its osteoperotic fracture treatment candidate trials.
Jim Cramer shares his views on the latest moves in biotech and retail. Account, Regeneron, Burlington Stores and Five Below are among the many stocks discussed here.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.